Clinical Trial

Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The main goal of this clinical trial is to determine the effect of flaxseed added to the diet on biochemical parameters and quality of life in patients with Type 2 diabetes mellitus (T2DM). The main questions it aims to answer are: * Does flaxseed supplementation given to T2DM patients for 12 weeks have an effect on biochemical parameters? * Does flaxseed supplementation given to T2DM patients for 12 weeks have an effect on quality of life? Researchers will compare patients with T2DM consume diet added flaxseed to a control group to see if flaxseed effect on biochemical parameters and quality of life. Participants will: * Complete the questionnaire, record the 3-day food consumption and be taken the anthropometric measurements at the beginning and end of the study. * Take diet added 30 g ground flaxseed (intervention group) or only diet (control group) every day for 12 weeks. * Visit the clinic once every 4 weeks for follow-up. * Report the dietary adherence and gastrointestinal symptoms on a phone call once every week.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-28.
Trial Details
NCT Number NCT06911060
Lead Sponsor Ondokuz Mayıs University
Conditions Type 2 Diabetes Mellitus (T2DM)
Enrollment 46 participants
Start Date 2025-09
Primary Completion 2026-04 (estimated)
Study Completion 2026-05-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-12